Lamisil Voetschimmelcrème (Terbinafine Hydrochloride)

Terbinafine blocks the fungal enzyme squalene epoxidase, causing a buildup of squalene and a shortage of ergosterol, which is vital for fungal cell membranes. This disruption leads to loss of membrane integrity and ultimately kills the fungus.

The specific amount and frequency of application are determined by the prescribing healthcare professional based on the infection type, severity, patient age and the area of skin being treated.

Safety information for topical terbinafine during pregnancy or lactation is limited. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with azole‑based topical antifungals, terbinafine has a different mechanism—squalene epoxidase inhibition—and often requires a shorter treatment duration. It is generally effective against dermatophytes that may be less responsive to azoles, though individual response can vary.

Store the cream at room temperature, away from direct sunlight and excessive moisture. Keep it in the original packaging to protect the formulation until the expiry date indicated on the label.

Clean and dry the affected skin area, then apply a thin layer of the cream to the lesion and a small margin of surrounding skin. Rub gently until absorbed, usually once or twice daily as directed by a healthcare professional.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and significant skin irritation. If any signs of a severe reaction appear, discontinue use and seek immediate medical attention.

Individuals with a known hypersensitivity to terbinafine or any component of the cream should avoid its use. It is also contraindicated on broken skin, mucous membranes, and in patients where a physician advises against topical antifungal therapy.